<p><b>A</b> Starting from the initial conditions described in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1002703#pcbi-1002703-g003" target="_blank">Figure 3</a>, the RANKL concentration, osteoclast population density (OC) and tumor density (Tumor) are shown at 30, 60 and 90 days, respectively. The outcomes for three different values of the host-RANKL level are shown. The computational domain is 15 mm long, but since the fields are symmetric, only the right half is shown. The y-axes have the following units: RANKL in pmol/mm; OC in cells/mm; tumor density is normalized between 0, when there is no tumor per unit length, and 1, when the unit space is fully occupied by tumor. The resorption fronts of osteoclasts...
Osteosarcoma, the most common malignant primary bone tumor, is currently treated with chemotherapy a...
Background: Osteosarcoma is the most frequent form of malignant pediatric bone tumor. Despite the cu...
Since all tumors are unique, they may respond differently to the same treatments. Therefore, it is n...
<p>Starting from the initial conditions described in <a href="http://www.ploscompbiol.org/article/in...
<p><b>A</b> Starting from the initial conditions described in <a href="http://www.ploscompbiol.org/a...
<p><b>A</b> Starting from the initial conditions described in <a href="http://www.ploscompbiol.org/a...
<p><b>A</b> Starting from the initial conditions described in <a href="http://www.ploscompbiol.org/a...
<p>Active osteoclasts () resorb bone () along the gradient (red) of the RANKL field (), and move fro...
Bone is a common site for cancer metastasis. To create space for their growth, cancer cells stimulat...
<div><p>Bone is a common site for cancer metastasis. To create space for their growth, cancer cells ...
<p>The set of initial conditions used for all simulations of the study. The initial RANKL field cons...
<p>Evolution in time of the bone density (A,B), the osteocytes (C,D), the osteoclasts (E,F), the ost...
Purpose: In vivo studies have focused on the latter stages of the bone metastatic process (osteolysi...
Advanced cancers, such as prostate and breast cancers, commonly metastasize to bone. In the bone mat...
Advanced cancers, such as prostate and breast cancers, commonly metastasize to bone. In the bone mat...
Osteosarcoma, the most common malignant primary bone tumor, is currently treated with chemotherapy a...
Background: Osteosarcoma is the most frequent form of malignant pediatric bone tumor. Despite the cu...
Since all tumors are unique, they may respond differently to the same treatments. Therefore, it is n...
<p>Starting from the initial conditions described in <a href="http://www.ploscompbiol.org/article/in...
<p><b>A</b> Starting from the initial conditions described in <a href="http://www.ploscompbiol.org/a...
<p><b>A</b> Starting from the initial conditions described in <a href="http://www.ploscompbiol.org/a...
<p><b>A</b> Starting from the initial conditions described in <a href="http://www.ploscompbiol.org/a...
<p>Active osteoclasts () resorb bone () along the gradient (red) of the RANKL field (), and move fro...
Bone is a common site for cancer metastasis. To create space for their growth, cancer cells stimulat...
<div><p>Bone is a common site for cancer metastasis. To create space for their growth, cancer cells ...
<p>The set of initial conditions used for all simulations of the study. The initial RANKL field cons...
<p>Evolution in time of the bone density (A,B), the osteocytes (C,D), the osteoclasts (E,F), the ost...
Purpose: In vivo studies have focused on the latter stages of the bone metastatic process (osteolysi...
Advanced cancers, such as prostate and breast cancers, commonly metastasize to bone. In the bone mat...
Advanced cancers, such as prostate and breast cancers, commonly metastasize to bone. In the bone mat...
Osteosarcoma, the most common malignant primary bone tumor, is currently treated with chemotherapy a...
Background: Osteosarcoma is the most frequent form of malignant pediatric bone tumor. Despite the cu...
Since all tumors are unique, they may respond differently to the same treatments. Therefore, it is n...